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Specificity of protein ubiquitylation is conferred by E3 ubiquitin (Ub) ligases. We have annotated ,617 putative E3s and
substrate-recognition subunits of E3 complexes encoded in the human genome. The limited knowledge of the function of
members of the large E3 superfamily prompted us to generate genome-wide E3 cDNA and RNAi expression libraries designed
for functional screening. An imaging-based screen using these libraries to identify E3s that regulate mitochondrial dynamics
uncovered MULAN/FLJ12875, a RING finger protein whose ectopic expression and knockdown both interfered with
mitochondrial trafficking and morphology. We found that MULAN is a mitochondrial protein – two transmembrane domains
mediate its localization to the organelle’s outer membrane. MULAN is oriented such that its E3-active, C-terminal RING finger is
exposed to the cytosol, where it has access to other components of the Ub system. Both an intact RING finger and the correct
subcellular localization were required for regulation of mitochondrial dynamics, suggesting that MULAN’s downstream
effectors are proteins that are either integral to, or associated with, mitochondria and that become modified with Ub.
Interestingly, MULAN had previously been identified as an activator of NF-kB, thus providing a link between mitochondrial
dynamics and mitochondria-to-nucleus signaling. These findings suggest the existence of a new, Ub-mediated mechanism
responsible for integration of mitochondria into the cellular environment.
Citation: Li W, Bengtson MH, Ulbrich A, Matsuda A, Reddy VA, et al (2008) Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases
Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle’s Dynamics and Signaling. PLoS ONE 3(1): e1487. doi:10.1371/journal.-
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INTRODUCTION
Most known functions of ubiquitin (Ub) require its covalent
attachment to target proteins (substrates), which is mediated by the
sequential action of an E1 activating enzyme, an E2 conjugase and
an E3 ligase [1]. E3s have the ability to bind both to an E2 (via a
RING finger, U box, or HECT ‘‘catalytic’’ domain) and to the
substrate –in many E3s, those two binding sites reside in the same
polypeptide. In addition, certain RING finger (RNF) proteins can
also be part of complexes where substrate recognition is assigned
to a separate subunit. In particular, the RNF proteins Rbx1/2 add
great diversity to E3s by forming SCF and SCF-like complexes
with alternative substrate-recognition subunits, often characterized
by the additional presence of an F box, SOCS box, DDB1 or BTB
domain [2,3].
Although the Ub-proteasome system (UPS) is known to be
involved in a number of cellular processes, the role of E3s in the
regulation and degradation of mitochondrial proteins and in
mitochondrial biology is only beginning to emerge. For one thing,
until recently, studies of mitochondrial protein degradation had
largely focused on the organelle’s autonomous and highly
conserved proteolytic system, including peptidases and ATP-
dependent proteases [4]. In fact, the UPS is not present within
mitochondria. However, Ub might conceivably target either
proteins that are integral to the mitochondrial outer membrane
(MOM) or cytoplasmic regulators of mitochondrial functions. The
regulation of mitochondrial dynamics by the UPS was first
suggested by work showing that the E3 Rsp5p plays an essential
role in this process [5]. Based in particular on studies with S.
cerevisiae we now know that mitochondrial fusion and fission factors
can become modified with Ub or Ub-like proteins [5–8]. For
example, the steady-state levels of the MOM fusion factor, Fzo1p,
are set by ubiquitylation mediated by the E3 Mdm30p followed by
proteasomal degradation [6]; the degradation of Fzo1p can also be
accelerated by a yet-to-be identified E3 in response to mating
pheromone [7]. Modification with the Ub-like protein SUMO
promotes the association of the cytosolic fission factor Drp1 with
mitochondria and increases its stability, presumably by competi-
tion with Ub [8]. In fact, a candidate E3 Ub ligase for Drp1,
MarchV/MITOL, which acted as a negative regulator of
mitochondrial fission, has been identified recently [9,10]. MarchV,
which until this work was the only transmembrane E3 known to
reside in the MOM, binds to Drp1 and mediates its ubiquitylation
and destabilization [9,10]. However, another recent report has
proposed the opposite function for MarchV [11], i.e., as a factor
required for mitochondrial fission. Thus, the picture clearly remains
incomplete.
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PLoS ONE | www.plosone.org 1 January 2008 | Issue 1 | e1487We reasoned that the discovery of new mechanisms of cellular
regulation involving the UPS could benefit from the development
of genome-wide tools to allow its specific manipulation, such as by
interfering with E3 levels. Here we report the annotation of the
E3s and substrate-recognition subunits of E3 complexes encoded
in the human genome. Based on the annotation information, we
generated genome-wide human and mouse cDNA and shDNA E3
collections ready for functional screening. In a cell-based imaging
screen for regulators of mitochondrial dynamics using these
collections, we identified an E3, FLJ12875, whose role in these
processes was made evident both through its ectopic expression
and through the knockdown of the endogenous gene. Since this E3
had been previously identified as an NF-kB activator [12] and we
found it to localize to mitochondria, we named it MULAN, for
Mitochondrial Ubiquitin Ligase Activator of NF-kB. MULAN is
anchored to the mitochondrial outer membrane through two
transmembrane domains, properly positioned such that its RNF
can have access to other UPS components in the cytosol. Both an
intact RNF and the E3’s mitochondrial localization were required
for interfering with mitochondrial dynamics.
RESULTS
Genome-wide annotation of the human E3
superfamily
We set out to annotate the minimal complement of genes encoding
putative human E3s, based on the presence of signature
‘‘catalytic’’ domains, as well as of domains characteristic of
substrate-recognition subunits of multi-subunit RNF-dependent
E3s. In addition, we annotated the genes encoding A20 finger
proteins and MALT1/paracaspase, which have recently been
found to act as E3s [13,14]. In contrast to two Ub E1 and the
estimated fewer than 40 Ub E2 genes (our unpublished
observations and [1]) and consistently with the role of E3s in
conferring substrate specificity to ubiquitylation, we uncovered
,617 genes encoding putative Ub E3s after searching a human
proteome superset and annotating the respective encoding loci. The
number of putative E3 genes is thus greater than the number of
human genes for protein kinases (518 genes; Tables 1 and S1). We
also found that ,95% of all E3s are RNF-dependent, with RNF
domain-encoding genes and multisubunit RNF-dependent E3s
represented in similar numbers (309 and 270 genes, respectively).
In S. cerevisiae, ,80 genes were found to encode putative E3s –of
these, 13 are essential for viability in rich medium, which mirrors
the proportion of all yeast genes estimated to be essential under
these conditions (17%; Tables 1–3). Thus, a similar fraction of all
yeast and human genes are dedicated to encode E3s (1–2%).
All but 75 human RNF proteins exhibit at least one other
domain that could be identified using publicly available protein
domain search databases. The 56 or more types of domains that
we found associated with the remaining RNF E3s (Table 4) could
play a variety of roles, including mediating interactions with
substrate degradation signals (degrons). This variety of domains is
consistent both with the diversity of proteins targeted for
ubiquitylation and with the diversity of mechanisms involved in
their recognition. Domain composition and protein homology
have been previously utilized to define subfamilies of RNF
proteins. The largest subfamily, TRIM/RBCC, has ,76 repre-
sentatives in humans (but none in S. cerevisiae) and is characterized
by the presence of a B box and a coiled coil ([15] and Table 5).
The second largest human RNF subfamily is the RBR/TRIAD
[16], with at least 14 members exhibiting two RNFs and an in-
between RING (IBR) domain (e.g., Parkin). Interestingly, many
RNF E3s are associated with other zinc-binding domains –
particularly zinc fingers of the C2H2, C3H1, UBR1 and RBZ
types (Table 4). Alignment of the RNF domain alone did not
reveal any new subfamilies of RNF proteins (unpublished
observations).
Functional genomics screening and identification of
MULAN, an E3 that regulates mitochondrial
dynamics
The discovery of new mechanisms of cellular regulation involving
the Ub-proteasome system (UPS) could benefit from the
development of functional genomics tools that allow its specific
manipulation, such as by interfering with E3 levels. With this in
mind, we hit-picked cDNA and plasmid-encoded RNAi (shDNA)
expression constructs representing nearly the entire human and
mouse E3 families from publicly available genome-wide collec-
tions, and individually arrayed these constructs in 384-well plates
for functional screens [17].
In one such screen, we set out to identify novel E3s that regulate
mitochondrial dynamics. Mitochondria divide, fuse and move
around cells [18–20], processes whose relevance is underscored by
the observation that mutations in the cognate proteins can lead to
disease, in particular neuronal dysfunction [19]. Mitochondria
utilize the cytoskeleton as tracks for directional movement –in
mammalian cells, they are distributed mainly along microtubules,
with kinesins (KIF) 1B and 5B having been identified as the
anterograde (plus end) trafficking motors [21]. A phenotype that is
characteristic of defective mitochondrial anterograde trafficking is
the perinuclear clustering of the organelle, which we observed
following transfection of HeLa cells with siRNA against KIF5B (a
gift of Dr. Jiang Wei, Burnham Institute; [22]); in contrast,
mitochondrial trafficking was not impaired in cells transfected with
siRNA to KIF11, which has not been implicated in mitochondrial
trafficking (Fig. 1A).
Table 1. Number of H. sapiens and S. cerevisiae predicted E3-
encoding genes.
......................................................................
Family human yeast
RING 300 47
Ub o x 9 2
HECT 28 5
F box 61 21
SOCS box 37 0
BTB 169 3
DDB1-like 3 2
ZnF A20 9 0
other 1 0
Total 617 80
RING finger E3s human yeast
single-subunit/U box 309 49
multi-subunit (SCF-like) 270 26
Total 579 75
Top 11 rows: numbers according to individual E3 families. ‘‘Other’’ refers to
paracaspase [13]. Bottom four rows: number of single-subunit (including U box)
and multi-subunit RNF E3s. ,95% of both human and budding yeast’s E3s are
RNF-dependent. Note that the SOCS and A20 E3 families are not represented in
budding yeast, and that BTB proteins are relatively underrepresented in yeast
compared to humans; in addition, in budding yeast there are nearly twice as
many predicted single-subunit as multi-subunit RNF E3s.
doi:10.1371/journal.pone.0001487.t001
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Ubiquitin and Mitochondria
PLoS ONE | www.plosone.org 2 January 2008 | Issue 1 | e1487Having validated a morphology-based imaging assay for
mitochondrial dynamics, we next screened our E3 collections by
transfecting HeLa cells together with a plasmid encoding a
mitochondrial-targeted red-fluorescent protein (MT-RFP, consist-
ing of RFP fused to the presequence of human cytochrome c
oxidase subunit VIII). This allowed visualization of mitochondria
specifically in E3-transfected cells. Following hit-picking and
reconfirmation of the results from the primary screens, we
uncovered MULAN, a putative E3 whose ectopic expression led
to defects in both mitochondrial morphology and subcellular
distribution (Fig. 1A). The phenotype of HeLa cells ectopically
expressing MULAN is characterized by the fragmentation of
otherwise long, tubular-shaped mitochondria (Figs. 1A and 1B). In
addition, as in the KIF5B knockdown, mitochondria in MULAN-
transfected cells clustered around the perinuclear region. These
phenotypes were MULAN dose-dependent (Fig. S1) and were
observed with all cell lines examined: HeLa, 293, NIH3T3,
Table 2. S. cerevisiae RNF E3s and their H. sapiens homologs.
......................................................................
S. cerevisiae name S. cerevisiae symbol Human homolog
APC11 YDL008W APC11
ASI1 YMR119W
ASI3 YNL008C
ASR1 YPR093C
BRE1 YDL074C RNF20 (RNF40)
CHF1/DMA1 YHR115C RNF8
CHF2/DMA2 YNL116W RNF8
CWC24 YLR323C RNF113/ZNF183
FAP1 YNL023C NFX1 ?
FAR1 YJL157C
HEX3/SLX5 YDL013W
HRD1/DER3 YOL013C AMFR
IRC20 YLR247C
ITT1 YML068W RNF14 ?
MAG2 YLR427W RNF10
MPE1 YKL059C RBBP6
NOT4/MOT2/SIG1 YER068W CNOT4
PEX10/PAS4 YDR265W PEX10
PEX12/PAS11 YMR026C PEX12
PEX2 YJL210W PEX2
PIB1 YDR313C
PSH1 YOL054W
RAD16/PSO5 YBR114W
RAD18 YCR066W RAD18
RAD5/REV2/SNM2 YLR032W SMARCA3/HLTF
RBX1/ROC1/HRT1 YOL133W RBX1
RIS1/DIS1 YOR191W
RKR1 YMR247C ZNF294
RMD5/GID2 YDR255C
SAN1 YDR143C
SLX8 YER116C
SNT2 YGL131C
SSL1 YLR005W GTF2H2
SSM4/DOA10 YIL030C MARCH family
STE5/HMD3/NUL3 YDR103W
TFB3/RIG2 YDR460W MNAT1
TUL1 YKL034W
UBR1/PTR1 YGR184C UBR1
UBR2 YLR024C UBR2
VPS11/PEP5/END1 YMR231W VPS11
VPS18/PEP3/VPT18 YLR148W VPS18
VPS8 YAL002W FLJ32099
YBR2 YBR062C
YDR266C
YHL010C BRAP
YKR017C
YOL138C
Sources of homology assignments were BLAST searches, Homologene, The
Saccharomyces Genome Database, The Sanger Center YOGY database and
manual curation. In bold, yeast genes essential for viability. Few human RNF E3s
have clear yeast homologs. Indeed, human RNF E3s are often associated with
signaling domains that are specific of metazoans (see Table 4).
doi:10.1371/journal.pone.0001487.t002
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Table 3. Predicted non-RNF E3s of S. cerevisiae grouped
according to family.
......................................................................
Protein family Gene name Gene symbol
Ubox PRP19 YLL036C
UFD2 YDL190C
HECT TOM1 YDR457W
HUL4 YJR036C
HUL5 YGL141W
UFD4 YKL010C
RSP5 YER125W
F BOX COS111 YBR203W
SAF1 YBR280C
MFB1 YDR219C
CDC4 YFL009W
MET30 YIL046W
YJL149W
RCY1 YJL204C
GRR1 YJR090C
HRT3 YLR097C
YLR224W
YLR352W
MDM30 YLR368W
UFO1 YML088W
SKP2 YNL311C
DIA2 YOR080W
ELA1 YNL230C
AMN1 YBR158W
CTF13/CBF3 YMR094W
RAD7 YJR052W
YDR306C
YMR258C
BTB YIL001W
YDR132C
YLR108C
DDB1-like RSE1 YML049C
CFT1 YDR301W
Columns 2 and 3: in bold, yeast genes essential for viability.
doi:10.1371/journal.pone.0001487.t003
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Ubiquitin and Mitochondria
PLoS ONE | www.plosone.org 3 January 2008 | Issue 1 | e1487COS7, H9c2 and HL1 (unpublished observations). Notably, the
phenotypes resulting from MULAN ectopic expression were
manifested rapidly, within 24 h of transfection.
The effects of MULAN on mitochondrial dynamics could be
indirect, e.g., as a result of the disruption of the microtubule
network. To examine this possibility, HeLa cells were co-
transfected with MT-RFP and either MULAN or the vector
control, and microtubules were visualized by staining with a-
tubulin antibody. The results showed no obvious differences in the
microtubule network between vector- and MULAN cDNA-
transfected cells (Fig. 1B). Thus, the altered mitochondrial
distribution in cells ectopically expressing MULAN was apparently
not due to microtubule disruption. However, these results do not
rule out the possibility that the E3 exerts more subtle effects on
microtubules that could not be detected with these analyses.
MULAN is a 40-kDa protein with orthologs identified from flies
to vertebrates, and in plants. As MarchV, it does not have an
obvious ortholog in yeast. Reciprocally, Mfb1p and Mdm30p,
budding yeast F-box E3 subunits that are essential for mitochon-
drial dynamics, are apparently not conserved in higher eukaryotes
[6]. One possibility to explain the lack of conservation of such
critical regulators of what is thought to be an essential process for
both yeast and human cells is that there are important distinctions
between the molecular mechanisms underlying mitochondrial
dynamics in these organisms. Of relevance is the observation that
mitochondrial trafficking in yeast largely relies on the actin
cytoskeleton network, while in mammalian cells mitochondria are
transported predominantly along microtubules [18,21]. Moreover,
E3 regulators of mitochondrial dynamics could function as
mediators of the response to organism-specific signaling, as is the
case of organellar trafficking along long motor neuron axons, a
process regulated both by synaptic activity and by secreted
molecules such as NGF and TNF (e.g., [21]).
MULAN exhibits two predicted transmembrane domains
(TMDs) as well as an evolutionarily conserved C-terminal RNF
domain (Fig. 1C and Fig. S1A, B). To determine whether
MULAN is a bona fide E3, a GST fusion with its RNF was tested
for the ability to mediate ubiquitylation in reactions utilizing the
promiscuous E2, Ubc4. The RNF from MULAN, under these
conditions, was nearly as potent for ubiquitylation as that of c-Cbl
(Fig. 1D). As is often the case in this type of assay, GST blots
Table 4. Protein domains predicted in RNF E3s.
......................................................................
Domain
Number of
RNF Genes Representatives
Transmembrane 46 AMFR, BFAR, BFP, MULAN, DCST1, IBRDC3,
PTD016, GOLIATH, RNF103, RNF121,
RNF122, RNF128, RNF13, RNF133, RNF139,
RNF145, RNF148, RNF149, RNF150, RNF152,
RNF167, RNF170, RNF175, RNF180, RNF182,
RNF183, RNF185, RNF186, RNF19, RNF26,
RNF5, ZFPL1, LL441061, ZNRF4, TRIM59,
SYVN1, MIR, MARCH1, MARCH2, MARCH3,
MARCH4, MARCH5, MARCH6, MARCH8,
MARCH9, RFP2
ZnF_C2H2 10 DPF1, HAKAI, ZNF598, FLJ2573J, UB1-D4,
RNF166, ZnF313, RNF125, RAG1, ZNF645
Protease-
Associated (PA)
9 RNF13, RNF130, RNF133, RNF148, RNF149,
RNF150, RNF128, RNF167, ZNRF4
ZnF_TRAF 8 PDZRN3, RNF151, TRAF2, TRAF3, TRAF4,
TRAF5, TRAF6, TRAF7
MATH 6 TRAF2, TRAF3, TRAF4, TRAF5, TRAF6,
TRIM37
ZnF_C3H1 6 MKRN1, MKRN2, MKRN3, MNAB, RNF113A,
RNF113B
BIR 5 cIAP1, cIAP2, BIRC4, livin, BIRC8
TPR 5 RAPSYN, TPRD1, LL286495, RNF127, RNF105
Ankyrin repeats 4 ANKIB1, MIB1, MIB2, BARD1
KH 4 LL92312, RKHD1, RKHD2, RKHD3
PDZ 4 LNX, LNX2, PDZRN3, PDZRN4
Swi-related 4 SHPRH, SMARCA3, MDMX, MDM2
WWE 4 DTX1, DTX2, DTX4, RNF146
LON 3 LONRF1, FLJ45273, RNF127
PEX 3 PEX10, PEX12, PEX2
SH2 variant 3 c-CBL, CBL-B, CBL-3
Ubiquitin-like 3 PARKIN, UHRF1, UHRF2
WD40 3 COP1, RFWD3, TRAF7
ZnF_C2HC 3 RBBP6, ZNRF1, ZNRF2
ZnF_RBZ 3 MDMX, RNF31, RBCK1
DEXDc 3 ATRX, SHPRH, SMARCA3
NEUZ 3 LINCR, NEURL, LL391849
ZnF_ZZ 3 MIB1, MIB2, ZSWIM2
BRCT 2 BARD1, BRCA1
FHA 2 CHFR, RNF8
SH3 2 SH3MD2, SH3RF2
ZnF_UBR1 2 UBR1, UBR2
ZnF_NFX 2 HOZFP, NFX1
SAM 2 BFAR, LRSAM1
CARD 2 cIAP, cIAP2
RWD 2 RNF14, RNF25
RPT 2 RNF187, LL390358
HELICc 2 SHPRH, SMARCA3
SRA 2 UHRF1, UHRF2
LRR 1 LRSAM1
RRM 1 cNOT4
VWA 1 SSL1
ZnF_UBP 1 BRAP
CUE 1 AMFR
RPT 1 ATRX
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Table 4. cont.
......................................................................
Domain
Number of
RNF Genes Representatives
AAA 1 LL57674
MAT1 1 MAT1
B41 1 MIR
Kinase 1 MEKK1
SAP 1 RAD18
ZnF_CHY 1 RCHY1
IQ 1 RNF32
See Pfam/SMART for domain definitions. This list is not exhaustive and is
subject to rapid change as novel domain-defining algorithms are included in
the databases. Shown are the number of RNF-encoding genes that also encode
the indicated domains. Evidently, a given domain can be present more than
once in certain proteins. In addition to those listed, we also found the following
domains, almost exclusively in the TRIM subfamily (protein numbers in
parentheses): B box (72), SPRY (58), PRY (28), BBC (11), FN3 (7), BROMO (4), PHD
(3), IG FLMN (3), NHL (3), ARF (1).
doi:10.1371/journal.pone.0001487.t004
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Ubiquitin and Mitochondria
PLoS ONE | www.plosone.org 4 January 2008 | Issue 1 | e1487revealed that reaction products consisted of, at least in part, the
auto-ubiquitylated GST-RING finger protein itself, and their
formation required E1, E2, E3 and Ub (unpublished observations).
We also examined whether the integrity of the MULAN RNF
domain was required for E3 activity. C339, one of the Cys residues
that are essential for maintaining the RNF structure through zinc
coordination, was mutated to Ala, resulting in abolished E3
activity (Fig. 1D). This result led us to ask whether the
mitochondrial morphology phenotypes associated with expression
of MULAN were also dependent on an intact RNF. NIH3T3 cells
transfected with MULAN wild-type or with RNF mutant
constructs were analyzed for mitochondrial distribution (Figs. 1E
and S1D). While mitochondria in ca. 52% of wild type MULAN-
transfected cells presented a trafficking defect, this number was
markedly reduced in cells expressing either the RNF-deleted E3
(1-301; 1%), or the C339A mutant (3%) (Fig. 1E). These mutants
were expressed at similar or higher levels than the wild-type (Figs.
S1D and S2A) and their lack of effect on mitochondrial dynamics
was even more evident when normalized to the wild-type
expression level (Fig. S1D). Thus, the simplest interpretation of
these results is that regulation of mitochondrial dynamics by
MULAN is dependent on its E3 activity. The results also suggest
that the mitochondrial phenotype that we observe due to MULAN
expression is not just a non-specific effect due to increased
expression of any protein on the mitochondrial surface.
Endogenous MULAN regulates mitochondrial
dynamics
To confirm that endogenous MULAN plays a role in mitochondrial
dynamics, we generated two different siRNA, siMULAN1 and
siMULAN2, which led to greater than 70% reduction of the
endogenous mRNA level two days after transfection of HeLa cells
(Fig. 2A; knockdown was also observed at the protein level, Fig.
S2C). The phenotype of MULAN knocked-down cells exhibited
similarities to that of cells ectopically expressing the E3, which is
not unprecedented (e.g., [23,24]) and could be due to a dominant
negative effect of the ectopically expressed protein (Fig. 2 and Fig.
S3). Mitochondria in 80–90% of MULAN siRNA-transfected cells
were clustered around the nucleus, although clustering was less
compact compared to that seen in response to ectopic MULAN
expression; in contrast, only 5–12% of cells transfected with the
control non-silencing siRNA exhibited this phenotype (siS-
crambled; Figs. 2A and 2C). Immunostaining with anti-a-tubulin
antibody in cells knocked down for MULAN did not reveal an
obvious disruption of the microtubule network (Fig. 2B). The fact
that the knockdown phenotype was specific to siRNA against
MULAN and that it was observed with two different siRNA
sequences argues against an off-target effect and confirms a role
for MULAN in the regulation of mitochondrial dynamics.
With regard to mitochondrial morphology, the phenotype of
MULAN-knockdown cells was not as evident as for cells
ectopically expressing the E3 (Fig. 2C and Fig. S3). In the latter,
mitochondrial clustering is accompanied by a high degree of
fragmentation and by the collapse of the mitochondrial network,
leaving little discernible tubular structure remaining; in MULAN-
knockdown cells, tubular-shaped mitochondria remain visible and
the increase in fragmentation relative to control cells is not as
marked. These results suggest that the increased mitochondrial
fragmentation in response to MULAN ectopic expression could
represent either a gain-of-function phenotype or a secondary
consequence of severely disrupted mitochondrial trafficking.
MULAN is a MOM protein with a C-terminal
cytosolic-facing RNF
To begin elucidating the mechanism by which MULAN affects
mitochondrial dynamics, we determined its subcellular localiza-
tion. Earlier results had already revealed that the protein’s
distribution was reminiscent of mitochondrial staining patterns.
Several lines of evidence indeed indicate that MULAN is a
mitochondrial protein: (i) the signal of C-terminal Flag-tagged
MULAN completely overlapped with that of co-transfected MT-
RFP (Fig. 3A, upper panels). The untagged MULAN 1-301 protein,
whose levels were high enough to be detected by immunocyto-
chemistry using anti-MULAN antibody, also colocalized with
MT-GFP (Fig. 3A, lower panels). Thus, both an untagged and the
C-terminal tagged E3 co-localized with mitochondria. The
specificity of MULAN localization is also revealed by the
observation that neither protein colocalized with the Golgi marker
lectin-Alexa 488 (Fig. S1E); (ii) lysates of 293 cells overexpressing
Table 5. Major RNF E3 subfamilies.
......................................................................
Protein Family
Number of
Genes Representatives
TRIM/RBCC 76 TRIML1,TRIM10, TRIM11, TRIM15, TRIM17,
TRIM2, TRIM21, TRIM22, TRIM23, TRIM25,
TRIM26, TRIM28, TRIM3, TRIM31, TRIM32,
TRIM33, TRIM34, TRIM35, TRIM36, TRIM37,
TRIM38, TRIM39, TRIM4, TRIM40, TRIM41,
TRIM42, TRIM43, TRIM45, TRIM46, TRIM47,
TRIM48, TRIM49, TRIM49L1, TRIM49L2,
TRIM49L3, TRIM5, TRIM50, TRIM51, TRIM39L,
TRIM52, TRIM54, TRIM55, TRIM56, TRIM58,
TRIM59, TRIM6, TRIM60, TRIM61, TRIM62,
TRIM63, TRIM64, TRIM65, TRIM67, TRIM68,
TRIM69, TRIM7, TRIM72, TRIM73, TRIM74,
TRIM75, TRIM8, TRIM9, RFPL4B, LL390231,
MID1, MID2, PML, RFP, RFP2, RFPL1, RFPL3,
RNF135, RNF39, TIF1, RFPL4A, LL399937
TRIAD/RBR 14 TRIAD3, C20orf18, IBRDC1, ANK1B1, ARI,
ARI2, IBRDC2, IBRDC3, PARKIN, PARC, RNF14,
RNF144, RNF19, RNF31
MARCH 9 MARCH1, MARCH2, MARCH3, MARCH4,
MARCH5, MARCH6, MARCH8, MARCH9,
LOC441061
GOLIATH 9 GOLIATH, RNF13, GRAIL, RNF133, RNF148,
RNF149, RNF150, RNF167, ZNRF4
POLYCOMB 8 PCGF1, PCGF2, PCGF3, PCGF5, PCGF6,
PCGF4, RING1, RNF2
TRAF 7 RNF151, TRAF2, TRAF3, TRAF4, TRAF5,
TRAF6, TRAF7
DELTEX 5 DTX1, DTX2, DTX4, DTX3L, RNF146, DTX3
IAP 5 cIAP1, cIAP2, BIRC4, livin, BIRC8
UBR 4 UBR1, UBR2, ZNF650, LOC51136
PRAJA 4 PJA1, PJA2, RNF126, ZNF364
RKHD 4 RKHD1, RKHD2, RKHD3, LOC92312
NEURALIZED 3 LL93082, NEURL, LL391849
PEX 3 PEX2, PEX10, PEX12
MAKORIN 3 MKRN1, MKRN2, MKRN3
LON-RF 3 FLJ45273, RNF127, LONRF1
SIAH 3 SIAH1, SIAH1L, SIAH2
CBL 3 c-CBL, CBL-B, CBL-3, (HAKAI?)
Proteins lacking a RNF domain are not listed (e.g., TRIM14, TRIM16, TRIM29).
Complete or partial annotation of some of the listed families had been
previously reported: general [3,32], TRIM [15,33,34], RBR [16,35,36], BTB [37,38]
and F box [39].
doi:10.1371/journal.pone.0001487.t005
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PLoS ONE | www.plosone.org 5 January 2008 | Issue 1 | e1487Figure 1. Identification of MULAN as a novel regulator of mitochondrial dynamics. A) Left 2 panels: Mitochondrial perinuclear clustering (a
consequence of defective trafficking) results from siRNA-mediated knockdown of KIF5B, but not of KIF11. HeLa cells were transfected with the
indicated siRNAs and mitochondria were visualized with MitoTracker Red. Right 2 panels: A cell-based imaging screen of E3 cDNA and shDNA
genome-wide collections led to the identification of MULAN, a RING finger protein whose ectopic expression resulted in mitochondrial perinuclear
clustering and fragmentation. For the screen, HeLa cells were co-transfected with mitochondrial-targeted RFP (MT-RFP) and with the E3 collections.
‘‘Control E3’’ refers to a random E3 cDNA which did not affect mitochondrial dynamics in the screen. B) Mitochondrial perinuclear clustering in
response to MULAN ectopic expression apparently does not result from disruption of the microtubule network. HeLa cells were co-transfected with
MT-RFP and either vector control or MULAN wild type cDNA. Cells were immuno-stained with anti-a-tubulin antibody to visualize the microtubule
network. Green, tubulin staining; red, mitochondria. C) MULAN’s schematic domain structure. Amino acid numbers indicated below. TMD,
transmembrane domain. RNF, RING finger. D) MULAN’s RNF has in vitro E3 activity. Reactions utilized GST fusions with the MULAN or c-Cbl RNFs as
E3s. Activity was dependent on an intact RNF, since it was not detected in reactions using the MULAN C339A RNF mutant. c-Cbl’s RNF was used as a
positive control. Negative controls were reactions lacking an E3 (No E3) or reactions added to SDS sample buffer at t=0 (unreacted). E) MULAN’s RNF
is required for the regulation of mitochondrial dynamics. NIH3T3 cells were transfected with vector, wild type MULAN cDNA or RNF-mutant cDNAs,
together with MT-RFP. Cells were fixed at 24 h post-transfection and the fraction of RFP-positive cells exhibiting perinuclear-clustered mitochondria
was scored (% trafficking defect). Data represent the average of at least 350 cells per condition, from 3–5 random 206 fields. Results are
representative of several experiments.
doi:10.1371/journal.pone.0001487.g001
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PLoS ONE | www.plosone.org 6 January 2008 | Issue 1 | e1487Figure 2. Knockdown of endogenous MULAN perturbs mitochondrial dynamics. A) Blue bars: MULAN mRNA knockdown. RNA was extracted from
HeLa cells 48 h after transfection with siRNA oligos targeting two different MULAN sequences, or with a negative control siRNA (siScrambled).
Knockdown efficiency was determined by quantitative real-time RT-PCR. Results were normalized to the level of the 36B4 mRNA, which was amplified
in the same multiplex reaction, as an internal control. Purple bars: MULAN knockdown leads to mitochondrial perinuclear clustering. HeLa cells were
transfected with the indicated siRNAs on day 1, followed by MT-RFP on day 2. Cells were fixed on day 3 and the percentage of RFP-positive cells with
perinuclear-clustered mitochondria was scored. B) The microtubule network is apparently intact in MULAN-knockdown cells. As in ‘‘A’’, except that
cells were fixed and stained with anti-a-tubulin antibody for analysis (green). C) Both MULAN ectopic expression and endogenous knockdown
indicate its role in mitochondrial dynamics. For ectopic expression, HeLa cells were transfected with vector or MULAN wild type cDNA together with
MT-RFP. Cells were fixed for analysis 24 h post-transfection. For siRNA-mediated knockdown, cells were transfected with siScrambled or siMULAN1 on
day 1 and with MT-RFP on day 2. Cells were fixed on day 3. Mitochondrial fragmentation and clustering were quantitated under 1006field. At least
100 cells were counted per condition and data represent average of three independent transfections.
doi:10.1371/journal.pone.0001487.g002
Ubiquitin and Mitochondria
PLoS ONE | www.plosone.org 7 January 2008 | Issue 1 | e1487Figure 3. MULAN is a mitochondrial outer membrane (MOM) protein with a cytosolic-facing C-terminal RING-finger. A) MULAN colocalizes with
MT-RFP/MT-GFP. NIH3T3 cells were transfected with Flag-tagged MULAN or untagged MULAN 1-301, together with MT-RFP (top panels) or MT-GFP
(bottom panels), followed by immunostaining with antibody against Flag (top; green) or MULAN (bottom; red). B) Left panel: MULAN-Flag co-
sediments with the mitochondrial protein, Tom20, in sucrose gradient. 293 cells transfected with MULAN-Flag were subfractionated by sucrose
gradient. MULAN-Flag, the MOM protein Tom20, and Golgin 97 in each fraction were detected by western blot. Right panel: endogenous MULAN co-
fractionates with mitochondria in sucrose gradient. 293F cells were Dounce-homogenized and centrifuged at 7506g to pellet nuclei and unbroken
cells. The post-nuclear supernatant was centrifuged at 12,5006g to obtain the heavy membrane (HM) and the cytosolic/light membrane (LM)
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PLoS ONE | www.plosone.org 8 January 2008 | Issue 1 | e1487MULAN-Flag were subjected to centrifugation in sucrose
gradient. Gradient fractions were run in SDS-PAGE and analyzed
by western-blot with different antibodies, revealing that MULAN’s
sedimentation was similar to that of the mitochondrial protein
Tom20 but not of the Golgi marker, Golgin 97 (Fig. 3B, left
panel); (iii) detergent-free lysates of untransfected 293F cells were
first fractionated by differential centrifugation. Mitochondria in
the heavy membrane (HM) fraction were further purified by
sucrose gradient centrifugation. Samples of the whole cell extract,
‘‘mitochondrial’’ fraction, and cytosolic and light membrane (LM)
fraction were normalized for protein amount and analyzed by
western-blot using antibodies against cytochrome c, Golgin 97,
calreticulin/Sec61, tubulin or EEA1 (markers for mitochondria,
Golgi, ER, cytosol and endosomes, respectively; Fig. 3B, right
panel). Consistently with the previous observations, the results
show that endogenous MULAN was abundant in the fraction
enriched for mitochondria, but was not detected in the fraction
enriched for Golgi, ER, cytosol and endosomes. Although some
Golgi material contaminated the ‘‘mitochondrial’’ fraction,
immunocytochemistry analyses also revealed that MULAN-Flag
did not detectably colocalize with lectin in intact cells (Fig. S1E). In
the case of the ER, there was also contamination of the
mitochondrial fraction with soluble ER luminal material (calreti-
culin) and the ER signal in immunocytochemistry was too disperse
to allow complete resolution from mitochondria (Fig. S1F).
However, we do not expect a significant fraction of MULAN to
be localized to the ER, since this organelle’s membrane-resident
marker Sec61 was not detected in the purified mitochondrial
fraction enriched for MULAN, and MULAN was not detected in
the LM fraction enriched for the ER (Fig. 1B); (vi) lastly, immuno-
electron microscopy analyses demonstrated that the MULAN
signal concentrated specifically around the circumference of
mitochondria (Figs. 3C and S1). The finding that MULAN
localizes to mitochondria is interesting because only one other
transmembrane E3 has been shown to reside in this organelle
[9,11]. These results suggest that MULAN’s effects on mitochon-
drial dynamics are direct.
We then set out to determine the localization and topology of
MULAN within mitochondria. To confirm that MULAN’s
predicted TM domains are functional, we generated MULAN-Flag
mutants with deletions of sequences encompassing the TMD1
(amino acids 9-29), TMD2 (amino acids 242-259), or both. Fig. 3D
shows that deletion of either TMD partially affected the co-
localization of MULAN with MT-RFP, and that deletion of both
TMDs completely mistargeted the protein. These results are
consistent with the prediction that MULAN is a transmembrane
protein, butdonotdistinguishwhether itsitsatthe outerorthe inner
mitochondrial membranes. Access to other components of the Ub
system would require MULAN to be localized to the MOM with the
RNF domain facing the cytosolic side. To test this possibility, we
performed a limited protease susceptibility experiment with purified
mitochondria. 293 cells expressing MULAN-Flag were homoge-
nized in isotonic sucrose buffer and intact mitochondria were
isolated by sucrose gradient purification. Mitochondria were
incubated with or without trypsin for various times and used for
western blots to detect MULAN-Flag, the intermembrane space
protein Smac, and the MOM protein Tom20. The results (Fig. 3E)
revealed that MULAN’s C-terminal Flag tag was readily susceptible
to trypsin digestion, its signal disappearing within 5 min of
treatment. Similar results were obtained with Tom20, while Smac
remained trypsin-resistant unless mitochondria were permeabilized
with 0.5% Triton X-100 prior to addition of the protease (Fig. 3E,
lower panel). Together, the results presented so far suggest that
MULAN is MOM-anchored through two transmembrane domains,
exposing a short N-terminus and the RNF-containing C-terminus to
the cytosol. This model predicts that its RNF should have access to
the remaining components of the Ub system and thus function as a
bona fide E3 in vivo (Fig. 3F).
Modulation of mitochondrial dynamics by MULAN
requires its proper localization to the organelle
We next investigated the mechanisms that target MULAN to
mitochondria and found that, as for certain other MOM proteins,
transmembrane sequences with moderate hydrophobicity and net
positive charge in flanking regions, known as signal-anchor or
TMD+ domains are involved ([25] and Figs. S4 and S5, Text S1).
For example, mutation of twopositively charged residues C-terminal
to TMD2 (R260A/K261A) led to MULAN’s targeting to the
endoplasmic reticulum (Fig. S4C); MULAN’s N-terminus also
seemed to influence proper targeting, since an N-terminal Flag tag
led to the protein’s cytosolic localization (Fig. S4D). To determine
whether modulation of mitochondrial dynamics by MULAN
requires its proper localization to the organelle, the TMD2-deleted
mutant, the R260A/K261A mutant, as well as N-terminal Flag
tagged protein were evaluated for the ability to promote perinuclear
clustering of mitochondria. The results in Fig. 4 show that
mistargeted MULAN mutants were defective in eliciting perinuclear
clustering, despite that all were expressed at levels comparable or
higher to the wild-type (Fig. S2B). Likewise, MULAN’s isolated
cytoplasmic domain (amino acids 260-352) had no effect on
mitochondrial distribution or morphology (unpublished observa-
r
fractions. The HM fraction was subjected to sucrose gradient to further purify mitochondria. Equal protein amounts (40 mg) were fractionated by SDS-
PAGE and blotted with anti-MULAN antibody to detect endogenous MULAN. Cytochrome c, Golgin 97, EEA1 and tubulin were used as markers for
mitochondria, Golgi, endosomes and cytosol, respectively. Calreticulin and Sec61 were both used as ER markers. C) Immuno-electron microscopy of
MULAN. COS7 cells transfected or not with MULAN-Flag were fixed and stained with anti-Flag antibody followed by gold-conjugated secondary
antibody for immuno-EM analysis. Left panel: BSA only (no primary antibody) control; inset: mitochondrion from an untransfected cell. Right panel:
mitochondria expressing MULAN-Flag. Scale bars are indicated. D) MULAN’s predicted transmembrane domains (TMDs) mediate localization to
mitochondria. NIH3T3 cells were co-transfected with Flag-tagged MULAN deletion mutants (green) and MT-RFP (red). Deletion of TMD1 (MULAN D2-
29; top row) or of TMD2 (MULAN D242-259; middle row) led to partial mislocalization of MULAN. The combined deletion of both TMDs led to
complete mislocalization of MULAN to the cytosol (MULAN D2-29+D242-259; bottom row). E) MULAN is a mitochondrial outer membrane (MOM)
protein. Mitochondria from 293 cells transfected with MULAN-Flag were purified by sucrose gradient. Intact mitochondria were treated with trypsin
for the indicated time, in the presence or absence of Triton X-100. The MULAN C-terminus was readily susceptible to trypsin digestion in intact
mitochondria, indicating that it sits in the MOM facing the cytosol. Controls are the MOM protein, Tom20, and the intermembrane space protein,
Smac. Smac only becomes sensitive to trypsin upon lysis of mitochondria with 0.5% Triton X-100 (lower panel). F) Topological model for MULAN on
the MOM, indicating its transmembrane domains (red) and RNF (green). The cytosolic-exposed RNF can have access to the remaining components of
the Ub system.
doi:10.1371/journal.pone.0001487.g003
Ubiquitin and Mitochondria
PLoS ONE | www.plosone.org 9 January 2008 | Issue 1 | e1487tions). Interestingly, although the TMD2-deleted mutant (D242-259)
still remained partially localized to mitochondria, it was completely
defective in promoting perinuclear clustering of the organelle,
perhaps suggesting that an intact MULAN structure is required for
interaction with other components of its pathway. The results above
are consistent with a model in which MULAN’s regulation of
mitochondrial dynamics involves signaling effectors that are either
integral to, or can peripherally associate with, mitochondria.
MULAN is most highly expressed in the human heart
To determine MULAN’s expression pattern, we used MULAN
cDNA to probe a Northern blot of RNA from several human tissues.
The result revealed a single, 2.4-Kb mRNA in most human tissues
tested, with highest levels in the heart (Fig. 5A). Consistently, semi-
quantitative RT-PCR analyses revealed that MULAN is also
expressed at high levels in isolated mouse and rat primary
cardiomyoctyes (Fig. 5B, left panels) as well as in the adult mouse
cardiomyocyte cell line HL-1 when compared to NIH3T3 cells or to
the rat skeletal muscle-like cell line H9c2 (Fig. 5B, right panels).
DISCUSSION
In this study we performed the genomic annotation of the human
E3 superfamily and identified ca. 617 genes encoding putative E3s
and substrate recognition subunits of multimeric E3 complexes.
While there is no definitive proof that all those genes encode bona
fide E3s or E3 subunits, we note that most of the annotated
domains have a general or quasi general function in mediating
ubiquitylation. This is certainly true for RNF-dependent E3s,
which account for ,95% of all human E3s. To our knowledge,
even in the case of RNF proteins whose E3 activity has not been
directly demonstrated, there is evidence for an involvement in
ubiquitylation. For example, the RNF protein Bard1 seems to be
Figure 5. MULAN is most highly expressed in the human heart. A) Full-length human MULAN cDNA was used as a probe for hybridization to
northern-blot of RNA from multiple human tissues. A single 2.4Kb band was detected for MULAN mRNA, in various tissues. B) RT-PCR of MULAN
mRNA showed higher expression in mouse and rat adult primary cardiomyocytes (ACM) and in the mouse HL-1 cardiomyocyte cell line, compared to
mouse NIH-3T3 cells and to the rat skeletal muscle-like cell line H9c2. 18S rRNA and Cyclophilin B were used as controls.
doi:10.1371/journal.pone.0001487.g005
Figure 4. Modulation of mitochondrial dynamics by MULAN requires its proper localization to the MOM. NIH3T3 cells were transfected with wild
type or mitochondrial localization-defective MULAN mutants, together with MT-RFP. C339A is the RING finger-mutant control. Cells were fixed 24 h
post-transfection and the percentage of RFP-positive cells with perinuclear-clustered mitochondria was determined.
doi:10.1371/journal.pone.0001487.g004
Ubiquitin and Mitochondria
PLoS ONE | www.plosone.org 10 January 2008 | Issue 1 | e1487inactive for ubiquitylation alone but stimulates the E3 activity of its
heterodimeric partner, BRCA1 [26].
Only a small fraction of all E3s has been functionally
characterized. Despite that, E3s have already been directly
implicated in many biological processes and diseases. Well known
examples are deregulation of the E3s BRCA1, Mdm2, VHL and
Skp2 in various cancers, and Parkin in Parkinson’s disease. As a
follow-up of a genomic annotation of the E3 superfamily, we have
generated plate-arrayed, genome-wide cDNA and shDNA E3
collections that can serve as tools for the functional analysis of E3
function. Because of the reduced size of such ‘‘protein family’’
collections relative to complete genomic collections of tens of
thousands of entities, the quality of screens can be improved by
testing samples in replicates, for example. It also makes it more
feasible to repeat screens and change variables, such as by using
different cell lines (e.g., to knock-down regulators whose mRNA
expression is cell type-specific). We expect that this tool will lead to
the discovery of novel mechanisms of biological regulation by Ub
as well as to new candidate drug targets. The cell-based imaging
screen that we described in this work exemplifies how our
collections could be utilized to discover novel E3s and to assign
novel functions to known E3s. Other screen readouts are
conceivable –for example, it should be possible to uncover E3s
that target a substrate of interest by using a substrate-reporter
fusion protein. Furthermore, screening could be applied to a
transcriptional reporter-based assay for a signaling pathway.
Mitochondrial dynamics is an essential aspect of the organelle’s
function. We reported above the identification of a novel regulator
of this process, the MULAN E3 ligase. Three general lines of
evidence strongly suggest that the role we uncovered for MULAN
in the regulation of mitochondrial dynamics is specific –the
protein’s localization, as well as its ectopic expression and loss-of-
function phenotypes. As a consequence of MULAN’s knockdown,
the marked phenotype was a profound effect on the distribution of
mitochondria. This phenotype is thus distinct from the one
resulting from knockdown of MarchV/MITOL, the only other
mitochondrial E3 described so far [9,10]. In the latter case,
increased mitochondrial fission and unaltered mitochondrial
distribution were observed, suggesting that MULAN and MarchV
play different roles in mitochondria (but see [11]).
How does MULAN work? Its effects on mitochondrial dynamics
are likely to be direct, since MULAN localizes to mitochondria and
those effectsrequiredMULAN’sproperlocalization to theorganelle.
We presume that it is less likely that MULAN’s primary role is on
fusion or fission, since these processes were unaffected upon
MULAN depletion. Moreover, co-expression of either an inhibitor
of mitochondrial fission (the GTPase-defective, dominant negative
Drp1
K38A mutant [27]) or the mitochondrial fusion factors Mfn1,
Mfn2 or OPA1 failed to reduce the mitochondrial fragmentation
induced by MULAN ectopic expression suggesting that MULAN’s
effects on mitochondrial morphology are unrelated to the canonical
fusion or fission pathways (unpublished observations). Instead, the
resultspresentedareconsistentwitharoleforMULANatthelevelof
trafficking regulation –both its ectopic expression and knockdown
led to altered mitochondrial distribution, without having apparent
effects on the microtubule network. MULAN is an active E3, and its
effects on mitochondrial dynamics also required an intact RNF
domain. Clearly, the identification of MULAN’s substrates, effectors
or interacting proteins should help determine its primary function.
Besides being the primary organelle for energy production,
mitochondria also play important roles in intracellular signaling –
most studied have been their roles in programmed cell death.
Signaling responses can also be triggered by mitochondrial systems
monitoring protein quality (e.g., [28]). In higher eukaryotes,
mitochondria signal stress to the nucleus through still poorly
characterized pathways involving the transcription factors CHOP,
C/EBPb or NF-kB [28,29]. So far, the most definitive link
connecting NF-kB activation to mitochondria is through MAVS, a
MOM-resident protein that participates in the host innate
immune response to viral infection [29]. However, the mecha-
nisms of NF-kB activation by MAVS remain unclear. MULAN
had been previously identified as an NF-kB activator [12] and we
were able to confirm those findings in our laboratory (unpublished
observations). The discovery that MULAN is an E3 anchored to
the MOM thus provides an important new link between
mitochondria and NF-kB activation and an exciting new
opportunity for elucidating how these organelles become integrat-
ed into the cellular environment.
MATERIALS AND METHODS
Genomic annotation
To identify putative E3-encoding genes, the human proteome
deduced from a superset combining 5 databases [RefSeq peptides,
predicted transcripts of the human genome assembly #36,
Ensembl release 39, transcripts and corresponding proteins
predicted by Celera (release R27), and a 2006 version of UniProt]
was searched with Hidden Markov Models designed for the
individual domains, using HMMER 2.3.2 (based on the Interpro
v.13.1, including but not limited to Pfam database v.20). The
related PHD, PIAS and LIM domains were excluded from the
analyses. Iterative BLAST searches (v.2.2.12) of the UniGene,
RefSeq and Ensembl were used to compile a complete list of
‘‘synonyms’’ (alternative accession numbers), and using database
cross-references subsequently unified by non-redundant identifiers
–EntrezGene IDs (or a Celera hCG in the absence of an Entrez
gene). In some cases, domain assignment or verification involved
manual comparison to the predicted domains of the proteins’
orthologs listed in Homologene. In a limited set, some manual
editing was also used to analyze and combine de novo gene model
predictions from genomic sequences (using the Genscan program,
Celera and Ensembl gene models) with split predictions into a full-
length gene model. Prediction of additional domains in RNF E3s
was performed with SMART (http://smart.embl-heidelberg.de/).
Plamids and constructs
Human full length MULAN cDNA (GenBank accession no.
NM_024544) constructs in the pME vector were previously
described [12]. Mouse full length MULAN cDNA (GenBank
accession no. NM_026689) was obtained from the Mammalian
Genome Collection. Vectors used to generate tagged MULAN
constructs were p3xFlag-CMV-14 (Sigma, Saint Louis, MO),
pFlag, EGFP-N3 and EGFP-C2 (Clontech, Mountain View, CA).
Point mutations were created using the QuickChange site-directed
mutagenesis kit (Stratagene, La Jolla, CA). Internal deletions were
generated using the inverse PCR method. All mutations were
verified by sequencing.
Antibodies
MULAN polyclonal antibodies were generated by immunizing
rabbits with a synthetic peptide corresponding to amino acids 57-
76 (conserved between human and mouse), EAPGKCVPYAVIE-
GAVRSVK. The peptide antibody was further affinity-purified
using an antigen column. Other primary antibodies used in this
study were: Rabbit polyclonal antibodies against Ub (Z0458,
DAKO, Carpinteria, CA), Tom20 (sc-11445, Santa Cruz
Biotechnology, Santa Cruz, CA), Smac (Imgenex Corp., San
Diego, CA), Sec61 (Dr. Nicholas Gekakis, TSRI) and Calreticulin
Ubiquitin and Mitochondria
PLoS ONE | www.plosone.org 11 January 2008 | Issue 1 | e1487(405-417, Calbiochem, San Diego, CA); Monoclonal antibodies
against Golgin-97 (CDF4, Molecular Probes, Carlsbad, CA), the
Flag tag (M2, Sigma), EEA1 (Transduction Laboratories,
Lexington, KY), cytochrome-c (7H8.2C12, BD Pharmingen, La
Jolla, CA) and alpha-tubulin (DM1A, Sigma). Secondary antibod-
ies used were: Alexa Fluor 488 goat anti-rabbit and goat anti-
mouse IgGs (Molecular Probes), Cy3 donkey anti-mouse IgG
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).
Cell culture, transfection and cDNA library screening
HEK293, NIH3T3 and HeLa cells were maintained in DMEM
supplemented with 10% FBS at 37uC in 5% CO2. DNA
transfection was performed with lipofectamine 2000 (Invitrogen,
Carsbad, CA) or Fugene 6 (Promega, Madison, WI). siRNAs were
transfected using lipofectamine 2000.
The E3 cDNA library was arrayed in a 384-well plate format,
ready for reverse transfection [17]. For the screen reported, each
cDNA was co-transfected with MT-RFP. 24 h after transfection,
cells were fixed in 4% formaldehyde and screened for cDNAs that
led to obvious changes in mitochondrial morphology under the
fluorescence microscope at 206magnification.
siRNA oligos utilized were: siMULAN1, GAGCGCCUGU-
GUAGUGUGUUU (Dharmacon, Lafayette, CO); siMULAN2,
CCGCGCCUUGCCAGAACCCAA (Qiagen, Valencia, CA);
siScrambled (Qiagen # 1022076); and siCyclophilinB (Dharma-
con). HeLa cells were transfected with siRNA on day 1 (at a final
concentration of 50–100 nM in the culture media) followed by
MT-RFP on day 2. Cells were harvested on day 3 either to collect
RNA, or for fixation with 4% formaldehyde. Fixed cells were used
to score for defective trafficking based on the perinuclear
clustering of mitochondria, or were subjected to immunocyto-
chemistry as described below.
Immunocytochemistry and confocal microscopy
For immunocytochemistry, cells were plated out on 35-mm glass
bottom dishes (MatTek Corp., Ashland, MA). Cells were fixed
with 4% paraformaldehyde in phosphate-buffered saline (PBS) for
15 min, washed with PBS, permeabilized with 0.2% Triton X-100
for 5 min, washed four times with PBS and blocked with 3%
bovine serum albumin, all at room temperature. Cells were then
incubated with primary antibodies for 2 h at room temperature,
washed three times with 0.2% Triton X-100, incubated with
secondary antibodies for 30 min and washed again. Samples were
mounted using Prolong Antifade (Invitrogen) and analyzed by
confocal microscopy using an Olympus Fluoview 500 laser
scanning confocal on an Olympus IX61 upright microscope.
GFP was imaged with the 488-nm line of the Argon laser, and the
emission filter was a 505–525 bandpass filter. RFP was imaged
with 543 nm laser line from a HeNe green laser, and the emission
filter was a 560–600 bandpass filter.
Immuno-gold electron microscopy
Immuno-gold electron microscopy was performed at the University
ofCalifornia, San Diego, EMcore. COS7cells expressing MULAN-
Flag were fixed in PBS containing 2% paraformaldehyde and 0.2%
glutaraldehyde. Fixed cells were washed with 0.15 M glycine/PBS,
embedded in 10% gelatin/PBS and infused overnight with 2.3 M
sucrose/PBS at 4uC. 1-mm
3 cell blocks were mounted onto
specimen holders and snap frozen in liquid nitrogen. Ultracryomi-
crotomy was carried out at 2100uC on a Leica Ultracut UCT with
EM FCS cryoattachment (Leica, Bannockburn, IL) using a Diatome
diamond knife (Diatome US, Fort Washington, PA). 60–70 nm
frozen sections were picked up with a 1:1 mixture of 2.3 M sucrose
and 2% methyl cellulose and transferred onto Formvar and carbon-
coated copper grids. Immunolabeling was performed by a slight
modification of the‘‘Tokuyasutechnique.’’Briefly,gridswereplaced
on 2% gelatin at 37uC for 20 min, rinsed with 0.15% glycine/PBS
and the sections were blocked using 1% cold water fish-skin gelatin.
Primary antibody against Flag was diluted 1/100. Incubation with
primaryantibodyfor1 hat roomtemperaturewasfollowedby5-nm
gold-conjugated goat anti-mouse IgG and IgM (RPN 430,
Amersham Pharmacia Biotech, Piscataway, NJ) and 10-nm gold-
conjugated goat anti-rabbitIgG (RPN421), bothdiluted 1/25 in1%
BSA/PBS at room temperature for 30 min. Grids were viewed and
photographed using a JEOL 1200EX II transmission electron
microscope (JEOL, Peabody, MA).
Gradient centrifugation, mitochondria isolation and
trypsin digest
For gradient centrifugation, HEK293 cells expressing MULAN-Flag
were harvested from a 10-cm dish, washed in PBS and collected by
centrifugation at 6006g for 5 min. Cells were then washed with HE
buffer(10 mMHepes-KOH,pH 7.5,and1 mMEDTA) containing
10% (wt/vol) sucrose. Cells were suspended in1 mlof the HEbuffer
with 20 mg/ml a2-macroglobulin and protease inhibitor cocktail.
Cells were passed through a 27 gauge needle five times for
homogenization and centrifuged at 6006g for 10 min to obtain a
post-nuclear supernatant. The supernatant was layered over a
discontinuous gradient of 40% and 60% sucrose in HE buffer (6.6
and 2.2 ml, respectively). The gradient was centrifuged at
100,0006g for 3 h. 1ml aliquots were collected, 100 ml of each
fraction was concentrated using microcon columns (Millipore,
Billerica, MA) and subjected to SDS-PAGE. Immunoblotting was
performed using anti-Golgin 97, anti-Tom20 and anti-Flag
antibodies. Highly purified mitochondria were isolated using
methods described by Rezaul and colleagues [30]. Cells were
harvested by centrifugation at 1000 rpm for 5 min at room
temperature, then resuspended in solution A (0.25 M sucrose,
20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2,
1 mM EDTA, 1 mM EGTA, 1 mM DTT) with protease inhibitor
cocktail (Sigma). The cellular suspension was homogenized with a
glass Dounce homogenizer with 40 times up and down passes of the
pestle. The homogenate was centrifuged at 7506g for 15 min. The
supernatant was centrifuged at 12,5006g for 25 min to collect crude
mitochondria. The pellet was resuspended in solution B (0.25 M
sucrose, 1 mM EDTA, 10 mM Tris-HCl pH 7.4) then layered on a
1 M/1.5 M discontinuous sucrose gradient and centrifuged at
60,0006g for 40 min. Mitochondria were collected from the
interface and washed with at least 5 volumes of solution A for
downstream applications. For trypsin digest, 50–100 mg of highly
purified mitochondria were incubated with or without 25 mg/ml of
trypsin protease in 50 ml total volume at 37uC for 5 sec, 5 min and
15 min, with or without 0.5% Triton-X 100. Reactions were
stopped with trypsin inhibitor and run on SDS-PAGE to probe with
anti-Flag, anti-Tom20 and anti-SMAC antibodies.
In vitro ubiquitylation assay
In vitro ubiquitylation was performed as described [31], with His-
Ubc4 and MULAN GST fusion proteins. GST fusion proteins
were expressed and isolated as described [31].
Gene expression analyses
RNA was isolated using the RNeasy kit (Qiagen). Semi
quantitative RT-PCR was performed using the Superscript II
reverse transcriptase (Invitrogen). TaqMan qRT-PCR was
performed using the one-step Superscript III platinum reagent
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PLoS ONE | www.plosone.org 12 January 2008 | Issue 1 | e1487(Invitrogen). Samples were run in triplicate as multiplexed
reactions with a normalizing internal control (36B4; probe and
primer were gifts of Dr. E. Saez, TSRI). MULAN probe and
primer were ordered from Applied Biosystems (Foster City, CA).
Northern blot was performed with a commercial 12-lane multiple
human tissue blot (Clontech) using full length human MULAN
cDNA to generate the probe.
SUPPORTING INFORMATION
Figure S1 MULAN features. A) Hydrophobicity plot predicts
two transmembrane domains in MULAN, amino acids 9-29 and
242-259. B) Alignment of the MULAN RNF from various species:
human (H. sapiens), mouse (M. musculus), frog (X. laevis), fish (D.
rerio), plant (A. thaliana), fly (D. melanogaster) and mosquito (A.
gambiae). *, Zn-binding residues. Dark blue, evolutionarily
conserved residues. C) Immuno-EM shows MULAN-GFP signal
in mitochondria (M) but not in the Golgi (G) or nucleus (N), e.g.
NIH3T3 cells transfected with MULAN-GFP were fixed and
stained with anti-GFP antibody followed by gold-conjugated
secondary antibody for immuno-EM analysis. Scale bar, 200nm.
D) Perinuclear clustering of mitochondria dependent on the dose
of ectopically expressed MULAN. Bar graphs: NIH3T3 cells were
transfected with the empty vector, a serial dilution of plasmid
encoding wild type MULAN cDNA, or the equivalent amount of
MULAN 1-301 cDNA, together with MT-RFP. Cells were fixed
at 24 h post-transfection and the percentage of MT-RFP positive
cells was determined. Western blot panels: In experiments performed
in parallel under the same conditions, whole cell extracts were
used in blots with MULAN antibody to determine the relative
levels of ectopically expressed protein for each plasmid dilution.
Anti-tubulin blot was used as a loading control. E) MULAN does
not colocalize with the Golgi marker, Lectin-Alexa 488. NIH3T3
cells were transfected with MULAN-Flag or untagged MULAN 1-
301, followed by immunostaining with antibody against Flag (top)
or MULAN (bottom), together with Lectin-Alexa 488 (green,
Molecular Probes). F) NIH3T3 cells were transfected with
MULAN-Flag, followed by immunostaining with antibody against
Flag (red) and the ER marker, calreticulin (green). The apparent
partial co-localization of MULAN with the ER is presumably an
artifact of the widespread ER signal.
Found at: doi:10.1371/journal.pone.0001487.s001 (6.16 MB TIF)
Figure S2 Expression of MULAN proteins. A) Peptide antibody
against MULAN amino acids 57-76 was used to blot whole cell
lysates of HEK293 cells transfected with MULAN wild type or
mutant constructs. B) Anti-Flag tag antibody was used to blot
whole cell lysates of HEK293 cells transfected with Flag-tagged
MULAN wild type or mutant constructs. All constructs were Flag
tagged at the C-terminus, except for the N-terminal tagged
MULAN (lane 5). C) siRNA-mediated knockdown of MULAN
protein. HeLa cells were transfected with the indicated siRNAs on
day 1, MULAN cDNA on day 2. Cells were harvested 48 h after
cDNA transfection. Whole cell lysates were blotted with anti-
MULAN antibody. In all panels, anti-a-tubulin blot was used to
control for protein loading.
Found at: doi:10.1371/journal.pone.0001487.s002 (1.77 MB TIF)
Figure S3 Both MULAN ectopic expression and endogenous
knockdown indicate a role in mitochondrial dynamics. For ectopic
expression, HeLa cells were transfected with vector or MULAN
wild type cDNA together with MT-RFP. Cells were fixed for
analysis 24 h post-transfection. For siRNA-mediated knockdown,
cells were transfected with siScrambled or siMULAN1 on day 1
and with MT-RFP on day 2. Cells were fixed on day 3. Fixed cells
were immunostained with anti-a-tubulin antibody (green) to
visualize the microtubule network. Mitochondria marked with
MT-RFP are shown in red.
Found at: doi:10.1371/journal.pone.0001487.s003 (7.74 MB TIF)
Figure S4 MULAN is targeted to mitochondria via signal-anchor
type transmembrane domains (TMDs) and its optimal targeting
requires multiple signals. NIH3T3 cells were transfected with the
indicated GFP-fusion proteins, Flag-tagged point mutants or
deletion constructs of MULAN. Localization of the proteins was
revealed by GFP fluorescence or Flag immunostaining (green).
Mitochondria were visualized using MT-RFP (red). A) MULAN
lacks an N-terminal mitochondrial signal peptide. Upper: the N-
terminal 33 amino acids of MULAN were not sufficient to target
GFP to mitochondria.Lower:MULAN’sN-terminal 10 amino acids
were not required for mitochondrial localization. B) Isolated TMDs
of MULAN combined with their flanking sequences were sufficient
to target GFP to mitochondria. Upper: TMD1 targeted GFP to
mitochondria when combined with a C-terminal stretch of basic
amino acids (1-60). Lower: TMD2 together with additional N- and
C-terminal sequences (amino acids 158-279) targeted GFP to
mitochondria. C) Mutation of the basic residues immediately
following TMD2 in the context of full-length MULAN-Flag
(MULAN R260A/K261A) led to mislocalization to the ER. Upper:
MULANR260A/K261AdoesnotcolocalizewithMT-RFP.Lower:
MULAN R260A/K261A colocalizes with the ER marker, calreti-
culin. D) N-terminal Flag-tagged MULAN localized to cytosol. E)
Deletion of the entire C-terminal cytoplasmic domain (MULAN 1-
263) or of the RING domain (MULAN 1-301) did not affect
MULAN’s mitochondrial localization. (See also Text S1.)
Found at: doi:10.1371/journal.pone.0001487.s004 (16.49MBTIF)
Figure S5 MULAN sequences including TMD2 and immedi-
ately neighboring residues (amino acids 238-263) are not sufficient
for targeting MULAN to mitochondria. NIH3T3 cells were
transfected with a construct encoding the MULAN 238-263
fragment C-terminal tagged with GFP, alone or together with
MT-RFP. Upper row: 238-263-GFP does not colocalize with the
mitochondrial marker MT-RFP. Lower row: 238-263-GFP
colocalizes with the Golgi marker, Golgin97.
Found at: doi:10.1371/journal.pone.0001487.s005 (5.93 MB TIF)
Table S1 List of the predicted H. sapiens E3s.
Found at: doi:10.1371/journal.pone.0001487.s006 (0.16 MBXLS)
Text S1
Found at: doi:10.1371/journal.pone.0001487.s007 (0.05 MB
DOC)
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